Tianjin Chase Sun Pharmaceutical Co.,Ltd

SZSE:300026 Rapporto sulle azioni

Cap. di mercato: CN¥11.9b

Tianjin Chase Sun PharmaceuticalLtd Gestione

Gestione criteri di controllo 3/4

Tianjin Chase Sun PharmaceuticalLtd Il CEO è Dan Zheng, nominato in Mar2017, ha un mandato di 7.67 anni. possiede direttamente 0.05% delle azioni della società, per un valore di CN¥ 5.88M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 7.7 anni e 5.2 anni.

Informazioni chiave

Dan Zheng

Amministratore delegato

CN¥2.6m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO7.7yrs
Proprietà del CEO0.05%
Durata media del management7.7yrs
Durata media del Consiglio di amministrazione5.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Seems To Use Debt Quite Sensibly

Nov 22
Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Seems To Use Debt Quite Sensibly

We Think That There Are More Issues For Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Than Just Sluggish Earnings

Nov 01
We Think That There Are More Issues For Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Than Just Sluggish Earnings

Investors Appear Satisfied With Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Prospects

Sep 26
Investors Appear Satisfied With Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Prospects

These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Is Using Debt Reasonably Well

There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Jun 12
There's No Escaping Tianjin Chase Sun Pharmaceutical Co.,Ltd's (SZSE:300026) Muted Earnings

Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

May 22
Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026) Has Announced A Dividend Of CN¥0.03

This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

May 21
This Broker Just Slashed Their Tianjin Chase Sun Pharmaceutical Co.,Ltd (SZSE:300026) Earnings Forecasts

Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 04
Tianjin Chase Sun PharmaceuticalLtd's (SZSE:300026) Sluggish Earnings Might Be Just The Beginning Of Its Problems

AMMINISTRATORE DELEGATO

Dan Zheng (60 yo)

7.7yrs

Mandato

CN¥2,608,700

Compensazione

Ms. Dan Zheng serves as General Manager of Tianjin Chase Sun Pharmaceutical Co.,Ltd since March 24, 2017 and serves as its Vice Chairman since April 24, 2019. She serves as Director of Tianjin Chase Sun Ph...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Dan Zheng
GM & Vice Chairman7.7yrsCN¥2.61m0.050%
CN¥ 5.9m
Wu Jun Lan
Executive GM12.9yrsCN¥1.81m0.050%
CN¥ 5.9m
Wu Sun
Deputy GMno dataCN¥979.30kNessun dato
Chun Xu Li
Deputy GMno dataCN¥1.11m0.022%
CN¥ 2.7m
Rui Qiang Chen
GM of Human Resource Center & Deputy GMno dataCN¥1.21m0.023%
CN¥ 2.7m
Kun Zhang
Deputy General Manager7.7yrsCN¥1.32m0.031%
CN¥ 3.7m
Xiao Zhong Lu
Deputy General Manager2.6yrsCN¥1.76mNessun dato

7.7yrs

Durata media

49yo

Età media

Gestione esperta: Il team dirigenziale di 300026 è esperto e expertise (durata media dell'incarico 7.7 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Dan Zheng
GM & Vice Chairman7.6yrsCN¥2.61m0.050%
CN¥ 5.9m
Wu Jun Lan
Executive GM5.6yrsCN¥1.81m0.050%
CN¥ 5.9m
Wu Sun
Deputy GM5.6yrsCN¥979.30kNessun dato
Chun Xu Li
Deputy GMless than a yearCN¥1.11m0.022%
CN¥ 2.7m
Xiaoqing Yao
Chairman24.2yrsCN¥2.66m10.24%
CN¥ 1.2b
Peng Fei Tu
Independent Director4.8yrsCN¥120.00kNessun dato
Dan Liang
Employee Representative Member of Supervisory Board & Securities Affairs Representative11.6yrsCN¥91.00kNessun dato
Shengtian Wang
Independent Director6.9yrsCN¥120.00kNessun dato
Tao Gong
Independent Director4.8yrsCN¥120.00kNessun dato
Li Li
Independent Director4yrsCN¥120.00kNessun dato
Sen Lin
Directorless than a yearNessun datoNessun dato
Juan Chen
Director1.3yrsNessun datoNessun dato

5.2yrs

Durata media

55yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 300026 sono considerati esperti (durata media dell'incarico 5.2 anni).